Hint mode is switched on Switch off

Opthea, American depositary receipt (ADR)
OPT, US68386J2087

FIND, SAVE & TRACK INVESTMENTS WITH CBONDS WATCHLIST

With Cbonds Watchlist you can always stay updated on your investments to make conscious decisions!

Watchlist
You need to request access
Add a stock to WL
Choose all Reset all
Ceryvyn Therapeutics, сountry — Australia
No trading data
Data display in a chart | table
Source of information - PJSC "MOEX". Further disctribution of MOEX information is prohibited without prior consent with PJSC "MOEX".
Source of information - PJSC "MOEX". Further disctribution of MOEX information is prohibited without prior consent with PJSC "MOEX".
No data
from
to
ADD-IN
Cbonds add-in API
bond data api
Authorization required
You need to request access
More than 2,500 records have been found, please specify your request
No data for the selected period
Welcome to Cbonds
New to Cbonds? · Take a 90-second tour of the platform.

Discover what you can do with Cbonds

Everything you need for fixed income research and monitoring.

  • 00:23 Coverage
  • 00:40 Bond screener
  • 00:54 Parameters
  • 01:10 Watchlist, Mobile app
  • 01:15 Excel Add-in
Get access Watch full tour

Latest quotes

Get access to the largest financial database

Try in 7-days Demo access

Free for company representative

  • Evaluate advanced analytical tools
  • Get full online access to the database
  • Try our powerful bond screener
  • Track bond prices from 400+ sources

Get access to the largest financial database

Representative of the company 7 days FREE trial

Professional access to the data

Private investor

Individual access

Issuer

Profile
Ceryvyn Therapeutics is a clinical-stage biopharmaceutical company developing innovative therapies by translating advances in human biology into transformative medicines for patients with serious diseases. The Company seeks to identify biological mechanis
  • Issuer
  • Full borrower / issuer name
    Ceryvyn Therapeutics Limited
  • Industry
    Pharmaceutical Preparation and Biotechnology

Placement data

  • Placement type
    IPO | Finished
  • Subscription type
    Open
  • Placement exchange
    NASDAQ
  • Ticker
    OPT
  • Placement
    16.10.2020
  • Lock up period
    180
  • Number of papers
    8,563,300
  • Volume of raised funds
    115.6 mln USD
  • Placement share
    20.29%
  • Final placement price
    13.5 USD
  • Price change since placement date
    -100%
  • By capitalization
    569.81 mln USD

IFRS/US GAAP reports

2025
II q eng
2024
II q eng
2023
II q eng
2022
II q eng
2021
II q eng
Show more Hide

Indicators

Other stocks and deposit receipts

Holders

Industry Leaders

Registration is required to get access.